Skip to main content
Featured products
CoraSim® is a heart simulator designed for training and education in cardiac electrophysiology…
Balloon dilatation catheter for percutaneous transluminal valvuloplasty, ideal for TAVI…
The OSYPKA PACE 300® is a three-chamber external pacemaker designed for temporary biventricular…
OSYPKA PACE 101H® is a single-chamber external pacemaker ideal for temporary cardiac pacing in…
The ICONCore® is a portable, non-invasive cardiometer that enables continuous measurement of…
Temporary myocardial pacing cables intended for use after cardiac surgery. Available in multiple…

    Extender paclitaxel-eluting PTA balloon

    A drug-eluting balloon (DCB) with paclitaxel for angioplasty in peripheral arterial disease above the knee.

    Extender paclitaxel-eluting PTA balloon

    A drug-eluting balloon (DCB) with paclitaxel for angioplasty in peripheral arterial disease above the knee.


    The Extender paclitaxel-eluting PTA balloon is a paclitaxel-coated balloon dilatation catheter, specially designed for percutaneous transluminal angioplasty (PTA) in the treatment of peripheral arterial disease (PAD). Optimized for supra-patellar peripheral interventions, the Extender paclitaxel-eluting PTA balloon combines mechanical efficacy with precise drug delivery. Its advanced coating allows for controlled administration of paclitaxel, a potent anti-restenotic agent, during brief inflations, reducing drug loss and maximizing its therapeutic efficacy. With a technology that improves drug retention at the lesion site, Extender offers a minimally invasive alternative to prevent restenosis after PTA procedures.

    Features

    • Paclitaxel-coated balloon to inhibit restenosis.
    • Designed for above-the-knee interventions.
    • Brief inflation with effective drug release.
    • Optimised coating for minimal drug loss.
    • High-performance and precise PTA catheter.

    Benefits

    • Significantly reduces restenosis in peripheral arteries.
    • Minimises patient exposure to repeated procedures.
    • Improves long-term vessel patency.
    • Rapid paclitaxel administration during inflation.
    • Optimises clinical outcomes in PAD patients.